Our body temperature may be inextricably tied to our mental health, research out this week suggests. A team of scientists has found evidence that higher body temp is associated with having clinical depression. While there are many unresolved questions about this link, the researchers have already begun to conduct…
Researchers at Stanford University say they’ve made the sort of discovery that you’d expect to see in a piece of science fiction. In a controlled and randomized trial published this week, they found evidence that people can be made more susceptible to hypnosis with just two short sessions of non-invasive brain…
New research might complicate our understanding of ketamine as a potential treatment for depression. The study found that people with depression who were either given saline or ketamine before undergoing anesthesia for a surgery experienced a similar improvement in their symptoms afterward. The findings suggest that…
The Food and Drug Administration is warning people to stay away from unapproved sources of ketamine. According to the agency, compounded ketamine is increasingly being sold as a treatment for depression and other mental health issues, despite it not being tested or authorized for such uses. The FDA also says it is…
New research could complicate the narrative over using exercise to help with depression and other mental health issues. A study compared depressed and/or anxious people who joined a running program to those who took a course of antidepressants, and found that both groups experienced a similar level of mental health…
New research appears to show that a ketamine-based nasal spray can outmatch a standard option for people with treatment-resistant depression. The large clinical trial found that people taking the spray in combination with other antidepressants were more likely to experience a sustained remission of their symptoms than…
New research out this week is the latest to show that psilocybin—the active ingredient in magic mushrooms—can be a viable treatment for depression. The randomized Phase II trial found that a single dose of psilocybin combined with therapy significantly reduced people’s depression symptoms when compared to placebo over…
